Leisure time physical activity is associated with improved HDL functionality in high cardiovascular risk individuals: a cohort study.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
13 10 2021
Historique:
received: 06 11 2019
accepted: 22 04 2020
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 5 4 2022
Statut: ppublish

Résumé

Physical activity has consistently been shown to improve cardiovascular health and high-density lipoprotein-cholesterol levels. However, only small and heterogeneous studies have investigated the effect of exercise on high-density lipoprotein functions. Our aim is to evaluate, in the largest observational study to date, the association between leisure time physical activity and a range of high-density lipoprotein functional traits. The study sample consisted of 296 Spanish adults at high cardiovascular risk. Usual leisure time physical activity and eight measures of high-density lipoprotein functionality were averaged over two measurements, one year apart. Multivariable linear regression models were used to explore the association between leisure time physical activity (exposure) and each high-density lipoprotein functional trait (outcome), adjusted for cardiovascular risk factors. Higher levels of leisure time physical activity were positively and linearly associated with average levels over one year of plasma high-density lipoprotein-cholesterol and apolipoprotein A-I, paraoxonase-1 antioxidant activity, high-density lipoprotein capacity to esterify cholesterol and cholesterol efflux capacity in individuals free of type 2 diabetes only. The increased cholesterol esterification index with increasing leisure time physical activity reached a plateau at around 300 metabolic equivalents.min/day. In individuals with diabetes, the relationship with cholesteryl ester transfer protein followed a U-shape, with a decreased cholesteryl ester transfer protein activity from 0 to 300 metabolic equivalents.min/day, but increasing from there onwards. Increasing levels of leisure time physical activity were associated with poorer high-density lipoprotein vasodilatory capacity. In a high cardiovascular risk population, leisure time physical activity was associated not only with greater circulating levels of high-density lipoprotein-cholesterol, but also with better markers of high-density lipoprotein functionality, namely cholesterol efflux capacity, the capacity of high-density lipoprotein to esterify cholesterol and paraoxonase-1 antioxidant activity in individuals free of diabetes and lower cholesteryl ester transfer protein activity in individuals with type 2 diabetes.

Identifiants

pubmed: 34647580
pii: 6396376
doi: 10.1177/2047487320925625
doi:

Substances chimiques

Cholesterol Ester Transfer Proteins 0
Cholesterol, HDL 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1392-1401

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Álvaro Hernáez (Á)

Hospital del Mar Medical Research Institute (IMIM), Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain.
CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.

Maria Trinidad Soria-Florido (MT)

Hospital del Mar Medical Research Institute (IMIM), Spain.

Olga Castañer (O)

Hospital del Mar Medical Research Institute (IMIM), Spain.
CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.

Xavier Pintó (X)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Spain.

Ramón Estruch (R)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain.
CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Hospital Clínic Barcelona, Spain.

Jordi Salas-Salvadó (J)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Spain.

Dolores Corella (D)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Universidad de Valencia, Spain.

Ángel Alonso-Gómez (Á)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Bioaraba Health Research Institute, University of the Basque Country UPV/EHU, Spain.

Miguel Ángel Martínez-González (MÁ)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Universidad de Navarra, Spain.
Harvard TH Chan School of Public Health, USA.

Helmut Schröder (H)

Hospital del Mar Medical Research Institute (IMIM), Spain.
CIBER Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Spain.

Emilio Ros (E)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Hospital Clínic Barcelona, Spain.

Lluis Serra-Majem (L)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Universidad de Las Palmas de Gran Canaria, Spain.

Miquel Fiol (M)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Balearic Islands Health Research Institute, Hospital Son Espases, Spain.

José Lapetra (J)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Distrito Sanitario Atención Primaria Sevilla, Spain.

Enrique Gomez-Gracia (E)

CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Universidad de Málaga, Spain.

Montserrat Fitó (M)

Hospital del Mar Medical Research Institute (IMIM), Spain.
CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.

Camille Lassale (C)

Hospital del Mar Medical Research Institute (IMIM), Spain.
CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Spain.
Department of Epidemiology and Public Health, University College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH